Cargando…
Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Prior analyses suggest that empiric fluconazole for ICU patients with sepsis is cost-effective. Using updated estimates of efficacy and cost, Zilberberg and colleagues compare the use of micafungin with that of fluconazole. The authors conclude that micafungin is an attractive alternative to flucona...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750174/ https://www.ncbi.nlm.nih.gov/pubmed/19725938 http://dx.doi.org/10.1186/cc7977 |